Journal of Advanced Biomedical Sciences
JABS
Sat, Oct 12, 2024
[Archive]
Volume 10, Issue 4 (11-2020)
JABS 2020, 10(4): 3028-3034 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Alipanah H, Ghanbariasad A, Osanloo M. Comparing the Cytotoxic Effects of Clove Essential Oil (Syzygium Aromaticum) and its Major Compound (Eugenol) Against Some Human Breast Cancer Cell Lines. JABS 2020; 10 (4) :3028-3034
URL: http://jabs.fums.ac.ir/article-1-2644-en.html
URL: http://jabs.fums.ac.ir/article-1-2644-en.html
1- Department of Physiology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran
2- Department of Medical Biotechnology, Schools of Medicine, Fasa University of Medical Sciences, Fasa, Iran
3- Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran ,osanloo_mahmood@yahoo.com
2- Department of Medical Biotechnology, Schools of Medicine, Fasa University of Medical Sciences, Fasa, Iran
3- Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran ,
Abstract: (1583 Views)
Background & Objective: Breast cancer is the most common cancer among women, especially in developed countries. Because of resistance to chemotropic drugs, the development of new green drugs is crucial. Essential oils with a broad range of bioactivities such as antioxidant and anticancer activities are great resources for research and development. In this study, anticancer effects of clove (Syzygium aromaticum) essential oil as the common medicinal plant against some human breast cancer cell lines was investigated.
Materials & Methods: Components of clove essential oil were identified. The anticancer effect of the essential oil and its major ingredient (eugenol) was investigated on four human breast cancer cell lines.
Results: Ninety-two percent of clove essential oil was included by eugenol (65%), trans-caryophyllene (12%), eugenol acetate (10%), caryophyllene oxide (3%), and a-humulene (2%). Both clove essential oil and eugenol showed proper effect (IC50 µg.mL-1) on targeted cell lines, MCF-7 (151.94 and 86.13), MDA-MB-175 (162.92 and 33.25), MDA-MB-231 (180.61 and 69.75), and MDA-MB-468 (211.11 and 53.91).
Conclusions: Regarding the proper anticancer effects of both samples, they could be considered as anticancer agents for further investigation.
Materials & Methods: Components of clove essential oil were identified. The anticancer effect of the essential oil and its major ingredient (eugenol) was investigated on four human breast cancer cell lines.
Results: Ninety-two percent of clove essential oil was included by eugenol (65%), trans-caryophyllene (12%), eugenol acetate (10%), caryophyllene oxide (3%), and a-humulene (2%). Both clove essential oil and eugenol showed proper effect (IC50 µg.mL-1) on targeted cell lines, MCF-7 (151.94 and 86.13), MDA-MB-175 (162.92 and 33.25), MDA-MB-231 (180.61 and 69.75), and MDA-MB-468 (211.11 and 53.91).
Conclusions: Regarding the proper anticancer effects of both samples, they could be considered as anticancer agents for further investigation.
Type of Study: Research |
Subject:
Pharmacology
Received: 2021/02/28 | Accepted: 2021/04/20 | Published: 2020/11/30
Received: 2021/02/28 | Accepted: 2021/04/20 | Published: 2020/11/30
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)